Transforming Growth Factor-β Pathway and Molecular Treatment of Liver Fibrosis
LU Lunge
Abstract
LU Lunge
Abstract
Many research studies have demonstrated that hepatic stellate cells (HSC) play a key role in fibrogenesis. Transforming growth factor-β (TGF-β) activates HSC and enhances the synthesis and deposition of extracellular matrix (ECM) in the liver. TGF-β-Smad signal pathway is the main pathway for TGF-β to exert its biological effects. The molecular constituents and modulation of this pathway are complicated, and have mutual influence with other signal pathways. Further study of TGF-β-Smad signal pathway not only enables the explanation for the pathogenesis of liver fibrosis, but also provides effective avenue for its prevention and treatment.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Many research studies have demonstrated that hepatic stellate cells (HSC) play a key role in fibrogenesis. Transforming growth factor-β (TGF-β) activates HSC and enhances the synthesis and deposition of extracellular matrix (ECM) in the liver. TGF-β-Smad signal pathway is the main pathway for TGF-β to exert its biological effects. The molecular constituents and modulation of this pathway are complicated, and have mutual influence with other signal pathways. Further study of TGF-β-Smad signal pathway not only enables the explanation for the pathogenesis of liver fibrosis, but also provides effective avenue for its prevention and treatment.
Key concepts: SMAD, Transforming growth factor, Extracellular matrix, Signal transduction, Hepatic stellate cell, Cell biology, Pathogenesis, Liver fibrosis